Structural Mechanism for GSDMD Targeting by Autoprocessed Caspases in Pyroptosis
Overview
Authors
Affiliations
The pyroptosis execution protein GSDMD is cleaved by inflammasome-activated caspase-1 and LPS-activated caspase-11/4/5. The cleavage unmasks the pore-forming domain from GSDMD-C-terminal domain. How the caspases recognize GSDMD and its connection with caspase activation are unknown. Here, we show site-specific caspase-4/11 autoprocessing, generating a p10 product, is required and sufficient for cleaving GSDMD and inducing pyroptosis. The p10-form autoprocessed caspase-4/11 binds the GSDMD-C domain with a high affinity. Structural comparison of autoprocessed and unprocessed capase-11 identifies a β sheet induced by the autoprocessing. In caspase-4/11-GSDMD-C complex crystal structures, the β sheet organizes a hydrophobic GSDMD-binding interface that is only possible for p10-form caspase-4/11. The binding promotes dimerization-mediated caspase activation, rendering a cleavage independently of the cleavage-site tetrapeptide sequence. Crystal structure of caspase-1-GSDMD-C complex shows a similar GSDMD-recognition mode. Our study reveals an unprecedented substrate-targeting mechanism for caspases. The hydrophobic interface suggests an additional space for developing inhibitors specific for pyroptotic caspases.
NLRP3 inflammasome in neuroinflammation and central nervous system diseases.
Xu W, Huang Y, Zhou R Cell Mol Immunol. 2025; .
PMID: 40075143 DOI: 10.1038/s41423-025-01275-w.
Kui W, Li Y, Gu Z, Xie L, Huang A, Kong S J Pain Res. 2025; 18:1115-1129.
PMID: 40070891 PMC: 11895692. DOI: 10.2147/JPR.S506569.
New insights into the noncanonical inflammasome point to caspase-4 as a druggable target.
Elkayam E, Gervais F, Wu H, A Crackower M, Lieberman J Nat Rev Immunol. 2025; .
PMID: 40044809 DOI: 10.1038/s41577-025-01142-9.
Qian Y, Liu Q, Cheng X, Wang C, Kong C, Li M Elife. 2025; 13.
PMID: 39998486 PMC: 11856931. DOI: 10.7554/eLife.99939.
GSDMD-mediated pyroptosis: molecular mechanisms, diseases and therapeutic targets.
Li Y, Guo B Mol Biomed. 2025; 6(1):11.
PMID: 39994107 PMC: 11850691. DOI: 10.1186/s43556-025-00249-8.